Invitae Invitae Launches Ciitizen Genome Information Management Platform at JPM The company believes the platform will expedite its longstanding goal of amassing genomic and other information from patients through their lifespan to fuel discoveries and improve care. Fulgent Genetics, Bio-Techne Lead Winners as GenomeWeb Index Gains 12 Percent in 2021 While Fulgent's stock price nearly doubled, at the other end of the spectrum, Berkeley Lights saw an 80 percent decline in its share price. GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month. Invitae Sues Natera Over Alleged Infringement of Sequence Assembly Patents Invitae is seeking damages and other costs, as well as an order enjoining Natera from infringing its '308 and '863 patents, which were granted last month. Invitae Unveils Plans to Expand Cancer Testing Portfolio Premium The company plans to launch a polygenic risk score, a germline-somatic test platform, and LDT and kitted tests for disease monitoring and therapy selection. Nov 8, 2021 Invitae Q3 Revenues Increase 66 Percent Oct 8, 2021 Invitae, Outcomes4Me Collaborate to Improve Breast Cancer Genetic Testing Access Sep 27, 2021 Beckman Coulter, Invitae Partner to Develop NGS Library Prep Applications Sep 27, 2021 Genetic Testing Results Influence Epilepsy Patient Care and Outcomes, Study Presented at NSGC Finds Sep 7, 2021 Invitae to Acquire Consumer Health Tech Firm Ciitizen for $325M Aug 30, 2021 Jury Awards ArcherDx, MGH $4.7M in Qiagen Patent Infringement Lawsuit Aug 10, 2021 Invitae Writes off $262.5M Liability Upon Failure to Meet Regulatory Milestone Aug 3, 2021 Invitae More Than Doubles Q2 Revenues Aug 2, 2021 GenomeWeb Index Gains Slightly in July as Fluidigm, PerkinElmer, Bio-Rad Post Strong Increases Jul 15, 2021 Children's National Hospital Wins $12.8M NIH Grant for Pediatric Mendelian Genomics Research Center Jul 2, 2021 Geisinger Trial to Evaluate Chatbot to Boost Cascade Testing in Familial Hypercholesterolemia Premium May 10, 2021 Invitae Sues Natera Alleging Infringement of Patent on DNA Sequencing Assembly Technique May 4, 2021 Invitae Q1 Revenues Increase 61 Percent Apr 14, 2021 Invitae, PCT Therapeutics, Genome Medical Partner to Offer Genetic Testing for Cerebral Palsy Apr 8, 2021 Invitae to Provide Genetic Testing Within eMERGE Population Screening Study Apr 5, 2021 Invitae Acquiring Genosity for $200M; Investment Group Provides Firm $1.15B in Senior Notes Mar 30, 2021 Renal Cell Carcinoma Risk Gene Representation Can Vary With Ancestry Feb 17, 2021 Invitae Q4 2020 Revenues Increase 51 Percent Feb 1, 2021 Oppenheimer Downgrades Invitae to Perform Rating Jan 29, 2021 Invitae, Decibel Therapeutics Launch Free Testing Program for Congenital Hearing Loss Load More Breaking News New Approach Identifies Candidate Causal Variants for Neuropsychiatric, Neurodevelopmental Conditions People in the News: Baylor's Thomas Caskey Dies; New Appointments at UK Biobank, CS Genetics, More In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable The Scan Omicron's Sewage Path The New York Times writes that testing sewage is helping public health officials track Omicron. IBM Sells Part of Watson Health The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm. Identifying the Right Whales The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought. Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.